Infection and Drug Resistance

Scope & Guideline

Transforming public health discourse on infectious diseases.

Introduction

Explore the comprehensive scope of Infection and Drug Resistance through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Infection and Drug Resistance in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1178-6973
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationINFECT DRUG RESIST / Infect. Drug Resistance
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Infection and Drug Resistance' focuses on the critical intersection of infectious diseases and antimicrobial resistance, providing a platform for research that contributes to the understanding, prevention, and treatment of infections. The journal emphasizes the need for innovative approaches in combating drug-resistant pathogens, aligning with contemporary global health challenges.
  1. Antimicrobial Resistance Mechanisms:
    Research on the genetic and phenotypic mechanisms of antimicrobial resistance in various pathogens, including bacteria, fungi, and viruses, is a primary focus, aiming to elucidate the pathways through which resistance develops and spreads.
  2. Infectious Disease Epidemiology:
    The journal publishes studies that analyze the epidemiological trends of infectious diseases, including their transmission dynamics, risk factors, and the impact of social and environmental determinants on disease outbreaks.
  3. Clinical Outcomes and Treatment Strategies:
    Articles explore clinical outcomes associated with different treatment regimens for infections, particularly those caused by multidrug-resistant organisms, and evaluate the efficacy and safety of novel therapeutic agents.
  4. Diagnostic Innovations:
    There is a strong focus on the development and validation of new diagnostic methods, including molecular techniques such as metagenomic next-generation sequencing, aimed at improving the speed and accuracy of pathogen identification.
  5. Public Health Interventions:
    The journal highlights studies on public health interventions and strategies for infection prevention and control, particularly in healthcare settings, to mitigate the impact of drug-resistant infections.
  6. Global Health Perspectives:
    Research articles often incorporate global health perspectives, addressing the challenges of infectious diseases and antimicrobial resistance in various geographical and socio-economic contexts.
The journal has seen a notable evolution in its focus areas, reflecting current global health challenges and emerging scientific advancements. This section outlines the new trends and topics that are increasingly becoming central to the journal's publications.
  1. Metagenomic Approaches:
    There is a rising trend in the application of metagenomic next-generation sequencing for diagnosing complex infections, allowing for a more comprehensive understanding of microbial communities and resistance profiles.
  2. Machine Learning and AI in Infectious Diseases:
    The integration of machine learning and artificial intelligence in predicting infection outcomes and resistance patterns is gaining traction, with studies exploring how these technologies can enhance clinical decision-making.
  3. Impact of COVID-19 on Other Infections:
    Research examining the impact of the COVID-19 pandemic on the epidemiology and management of other infectious diseases, including the resurgence of previously controlled infections, is increasingly relevant.
  4. Vaccination Strategies and Acceptance:
    With the ongoing vaccination efforts against COVID-19 and other infectious diseases, research on vaccine uptake, acceptance, and the associated factors is becoming a significant focus area.
  5. One Health Approach:
    The journal is increasingly publishing articles that adopt a One Health perspective, addressing the interconnectedness of human, animal, and environmental health in the context of infectious diseases and antimicrobial resistance.
  6. Public Health Strategies for Infection Control:
    There is a growing emphasis on evaluating and developing public health strategies and interventions for infection prevention and control, particularly in healthcare settings and during outbreaks.

Declining or Waning

While 'Infection and Drug Resistance' has maintained a robust focus on antimicrobial resistance and infectious diseases, certain areas of research have seen a decline in publication frequency or relevance. These waning scopes highlight shifts in research priorities or emerging challenges that may overshadow previously popular topics.
  1. Traditional Antibiotic Approaches:
    Research focusing solely on conventional antibiotic therapies without considering resistance mechanisms or the need for combination therapies has declined as the field shifts towards more integrated approaches to combat resistance.
  2. Single-Agent Studies:
    Studies evaluating the efficacy of single-agent antibiotic therapies have become less frequent as the understanding of polymicrobial infections and the need for combination therapies gains prominence.
  3. Basic Laboratory Research:
    There is a noticeable decline in purely basic laboratory studies that do not translate into clinical relevance or application, as the journal increasingly prioritizes translational research with direct implications for patient care.
  4. Historical Epidemiological Data:
    Research that focuses solely on historical epidemiological data without providing insights into current trends or implications for practice appears to be waning, reflecting a shift towards real-time data analysis and its application in public health.

Similar Journals

Infectious Microbes & Diseases

Elevating the discourse on infectious diseases and microbiology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

Mediterranean Journal of Infection Microbes and Antimicrobials

Innovating solutions for a healthier tomorrow.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Archives of Clinical Infectious Diseases

Empowering Professionals with Cutting-Edge Research
Publisher: BRIEFLANDISSN: 2345-2641Frequency: 4 issues/year

Archives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.

Infektsiya i Immunitet

Illuminating the path in immunology and infection studies.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

Infection and Chemotherapy

Innovative Insights into Infection Management and Therapy
Publisher: KOREAN SOC ANTIMICROBIAL THERAPYISSN: 2093-2340Frequency: 4 issues/year

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Transforming healthcare through impactful research.
Publisher: ELSEVIER TAIWANISSN: 1684-1182Frequency: 6 issues/year

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

CLINICAL MICROBIOLOGY AND INFECTION

Championing Discoveries in Infectious Disease Management
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

Journal of Global Antimicrobial Resistance

Advancing global solutions to antimicrobial resistance.
Publisher: ELSEVIER SCI LTDISSN: 2213-7165Frequency: 4 issues/year

The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.

Microbial Drug Resistance

Illuminating the Path to Effective Antimicrobial Strategies
Publisher: MARY ANN LIEBERT, INCISSN: 1076-6294Frequency: 10 issues/year

Microbial Drug Resistance, published by MARY ANN LIEBERT, INC, is a pivotal journal that explores the critical intersection of microbiology and pharmacology with a keen focus on antibiotic resistance and related issues. Since its inception in 1995, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for innovative studies that inform the global response to antimicrobial resistance. With a commendable position in the Category Quartiles, ranked Q2 in Medicine (miscellaneous) and Q2 in Pharmacology for 2023, it caters to a multidisciplinary audience by addressing the implications of microbial resistance within various medical contexts. Although currently non-Open Access, the journal allows subscribers and institutions to access high-quality, peer-reviewed research, directly impacting policy and practice in healthcare settings. Committed to advancing our understanding and combating the challenges posed by resistant microbes, Microbial Drug Resistance remains an essential publication in the fields of microbiology, immunology, and pharmacology.

Antimicrobial Resistance and Infection Control

Elevating awareness and research on resistance challenges.
Publisher: BMCISSN: 2047-2994Frequency: 1 issue/year

Antimicrobial Resistance and Infection Control is a leading open access journal published by BMC, dedicated to the dissemination of research in the critical area of antimicrobial resistance and its impact on infection control practices. Since its inception in 2012, the journal has quickly established itself as a vital resource for researchers, healthcare professionals, and policymakers, featuring a robust array of studies that address the escalating threats posed by antimicrobial resistance across various contexts. With its impressive Q1 rankings across multiple categories—including Infectious Diseases, Microbiology, Pharmacology, and Public Health—the journal’s influence is underscored by its consistent placement in the upper echelons of academic research. Furthermore, it holds commendable ranks in Scopus, with percentiles placing it in the top tier of its respective fields. The journal serves as an essential platform for innovative research and discussions aimed at curbing the threats of antimicrobial resistance, thereby supporting the global health community in striving for effective solutions to safeguard public health.